AAP
ASTH icon

Arax Advisory Partners’s Astrana Health ASTH Stock Holding History

Arax Advisory Partners’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-206
Closed -$5.11K – 4403
2025
Q4 		$5.11K Sell
206
-2
-1% -$53 ﹤0.01% 2838
2025
Q3 		$5.9K Buy
208
+155
+292% +$4.2K ﹤0.01% 2814
2025
Q2 		$1.32K Buy
+53
New +$1.49K ﹤0.01% 2693
2025
Q1 		– Sell
-16
Closed -$505 – 3091
2024
Q4 		$505 Sell
16
-62
-79% -$2.94K ﹤0.01% 2324
2024
Q3 		$4.52K Hold
78
– – ﹤0.01% 1761
2024
Q2 		$3.16K Buy
+78
New +$3.09K ﹤0.01% 1804

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return